---
title: "EML: Net income surged in Q2 2026 on acquisition gains, despite a 12% drop in net sales"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295581339.md"
description: "Q2 2026 net sales declined 12% year-over-year, but net income rose to $5.6 million due to a $6.5 million bargain purchase gain from acquisitions. Backlog increased 45% to $126.2 million, and liquidity remains strong with $59 million available under the credit facility.Original document: Eastern Company (The) [EML] SEC 10-Q Quarterly Report — Aug. 12 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-11T21:09:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295581339.md)
  - [en](https://longbridge.com/en/news/295581339.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295581339.md)
generator: "portal-rs"
---

# EML: Net income surged in Q2 2026 on acquisition gains, despite a 12% drop in net sales

Q2 2026 net sales declined 12% year-over-year, but net income rose to $5.6 million due to a $6.5 million bargain purchase gain from acquisitions. Backlog increased 45% to $126.2 million, and liquidity remains strong with $59 million available under the credit facility.

Original document: Eastern Company (The) \[EML\] SEC 10-Q Quarterly Report — Aug. 12 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [EML.US](https://longbridge.com/en/quote/EML.US.md)

## Related News & Research

- [EML: Backlog surged 45% year-over-year, supporting a strong outlook and margin recovery in H2 2026](https://longbridge.com/en/news/295680797.md)
- [Why Jeff Dean says he left Google after 27 years to build a 4-person AI startup](https://longbridge.com/en/news/296463114.md)
- [Most of Gen Z is now afraid AI will steal their jobs.](https://longbridge.com/en/news/296492576.md)
- [Workday stock is downgraded after buyout report as growth expectations are 'too optimistic'](https://longbridge.com/en/news/296104750.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**